However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...

The company's product is used to quickly delivery fluid and blood to patients suffering from life-threatening conditions.

Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~~ Catamaran® ...

The fund posted returns of -8.85% (Institutional shares) and -8.93% (Investor A shares, without sales charge) for the fourth ...

President Trump has been vocal about prioritizing the growth of U.S. companies and citizens since his campaigning days. The ...

Boston Scientific Corporation (BSX) is gaining investor attention, including Marshall Wace LLP, which holds nearly $792 ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Under the terms of the new Contract Manufacturing Agreement, effective as of March 17, 2025, AVITA Medical is to manufacture PermeaDerm at its state-of-the-art manufacturing facility in Ventura, ...

Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.

Corum announces today that their client, Austin-headquartered ImplantBase, a premier provider of inventory logistics and ...

Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury ...